PennHIP is Moving!

 

Greetings from PennHIP,

In mid November, the PennHIP Analysis Center and the PennHIP Administrative Center will be joining together as a single office.  We will be occupying a larger and more efficient space at the University of Pennsylvania School of Veterinary Medicine. 

 
The Analysis Center will be accepting radiographs up until November 16, 2009.  While correspondence will then be forwarded to our new Philadelphia address (see below), we suggest that your practice begin sending images and correspondence to the new address immediately.

We will do our best to ensure that you do not experience any disruption in service during the transition period. 

Thank you in advance for your patience and understanding.

Please send all correspondence, radiographs, CD's to:

PennHIP
University of Pennsylvania School of Veterinary Medicine
3800 Spruce Street
Philadelphia, PA  19104
USA

 

 

Sincerely,

Gail K. Smith, VMD, PhD

Director, PennHIP

 

Welcome to PennHIP

 

Canine Hip Dysplasia (CHD) afflicts millions of dogs each year and can result in debilitating osteoarthritis (OA) of the hip. It is estimated that more than 50% of the most popular large breed dogs will show x-ray evidence of CHD. Many will suffer from osteoarthritis, pain, and lameness, costing owners and breeders millions of dollars in veterinary care, shortened work longevity, and reduced performance.

PennHIP (University of Pennsylvania Hip Improvement Program) is a not-for-profit program, wholly owned and operated, by the University of Pennsylvania. It consists of 3 integral components:

  • An evidence-based radiographic technology to accurately screen canine hips for the susceptibility to OA.

  • A worldwide network of trained veterinarians to perform the procedure with competence.

  • A database maintained at the University of Pennsylvania designed to accumulate and report on breed-specific trends in OA and hip dysplasia control.

PennHIP's mission is to develop and apply evidence based technology to direct appropriate breeding strategies aimed at reducing in frequency and severity the osteoarthritis of canine hip dysplasia. The beneficiaries of this effort will be the many dogs who suffer with this controllable genetic disease and, of course, the dogs' owners.

PennHIP incorporates a new method for evaluating the integrity of the canine hip. It is accurate in puppies as young as 16 weeks of age. It has great potential to lower the frequency of CHD when used as a selection criterion.

 


 

Print this Page | Send to a Friend